3.42
0.07 (2.09%)
0.07 (2.09%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.07 | 2.09% | 3.42 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 3.42 | 3.2151 | 3.47 | 3.35 | 3.35 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.23 | 4.19 | 1.96 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,299 | 192,125 | $ 3.36 | $ 645,236 | 195,370 | 1.60 - 5.7703 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 18,058 | $ 3.42 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 160.61M | 46.96M | 27.61M | $ 3.67M | $ - | -1.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 3.30% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.27 | 3.57 | 3.2151 | 3.41 | 165,173 | 0.15 | 4.59% |
| 1 Month | 3.57 | 3.75 | 2.96 | 3.30 | 195,179 | -0.15 | -4.2% |
| 3 Months | 3.96 | 5.28 | 2.96 | 4.05 | 243,716 | -0.54 | -13.64% |
| 6 Months | 2.08 | 5.7703 | 1.91 | 3.76 | 292,739 | 1.34 | 64.42% |
| 1 Year | 3.81 | 5.7703 | 1.60 | 3.71 | 254,108 | -0.39 | -10.24% |
| 3 Years | 17.40 | 32.25 | 1.60 | 6.77 | 243,366 | -13.98 | -80.34% |
| 5 Years | 17.40 | 32.25 | 1.60 | 6.77 | 243,366 | -13.98 | -80.34% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
